Dimension Therapeutics Inc Stock

Stocks

03/10/17	Dimension (DMTX) Alert: Johnson Fistel Investigates Proposed Sale of Dimension Therapeutics, Inc.; Are Shareholders Getting a Fair Price?	PR
02/10/17	Dimension Board Determines that Ultragenyx’s Unsolicited Proposal to Acquire Dimension for $6.00 Per Share Constitutes a “Superior Proposal”	GL
19/09/17	Dimension Board of Directors Determines Proposal from Ultragenyx Pharmaceutical Inc. Could Reasonably Be Expected to Lead to a “Superior Proposal”	GL
18/09/17	Dimension Confirms Receipt of Unsolicited Proposal from Ultragenyx	GL
05/09/17	Dimension Therapeutics : OncoSec Appoints Industry Veteran Annalisa Jenkins MBBS, FRCP to Board of Directors	PR

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DIMENSION THERAPEUTICS INC	-.--%	-0.42%	-	-	0
WUXI APPTEC CO., LTD.	-6.60%	-8.56%	+49.38%	+64.90%	65B
LONZA GROUP AG	+0.03%	+5.56%	+9.10%	+75.22%	51.2B
ARGENX SE	-4.09%	-0.11%	+2.22%	+55.67%	51.19B
IQVIA HOLDINGS INC.	-1.53%	+2.70%	+30.48%	+41.25%	43.93B
BEONE MEDICINES AG	-1.34%	+4.12%	+16.64%	+120.28%	41.96B
REVOLUTION MEDICINES, INC.	-5.97%	-6.22%	+228.95%	+483.48%	38.14B
CELLTRION, INC.	+6.53%	+8.02%	+16.40%	+56.32%	33.24B
WUXI BIOLOGICS (CAYMAN) INC.	-0.90%	-10.49%	+37.09%	+1.80%	25.2B
GENMAB A/S	-1.07%	+2.33%	+19.43%	+20.40%	22.5B
Average	-1.49%	-0.35%	+45.52%	+102.15%	41.37B
Weighted average by Cap.	-2.20%	-0.50%	+44.25%	+103.65%

Employees

Sector